Skip to main content
SpringerLink
Log in

Gebräuchliche Hormone und Zytostatika

  • Chapter
Internistische Krebstherapie

  • 17 Accesses

Zusammenfassung

Die Anwendung von Hormonpräparaten bezeichnet man als additive, den Entzug von Hormonen als ablative Hormontherapie.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literaturverzeichnis

  1. Principles of chemotherapy. In: HOLLAND, J.F., FREI, E. III (Eds.): Cancer medicine, S.601. Philadelphia: Lea & Febiger 1973.

    Google Scholar 

  2. CHABNER, B.A., MYERS, C.E., COLEMAN, N., JOHNS, D.G.: Clinical pharmacology of antineoplastic agents. New Engl. J. Med. 292, 1107, 1159 (1975).

    Article  PubMed  CAS  Google Scholar 

  3. BOESEN, E., DAVIS, W.: Cytotoxic drugs in the treatment of cancer. London: Edward Arnold 1969.

    Google Scholar 

  4. GOODMAN, L.S., GILMAN, A. (Eds.): The pharmacological basis of therapeutics. London-Toronto: MacMillan 1971.

    Google Scholar 

  5. GREENWALD, E.S.: Recent advances in medicine and surgery: Cancer chemotherapy. N.Y. St. J. Med. 72, 2541, 2641, 2757 (1972).

    Google Scholar 

  6. HALL, T.C., KARRER, K.: Cancer chemotherapy — dose schedules and combinations. Wien: Verlag der Wien. Med. Akademie 1968.

    Google Scholar 

  7. MAYR, A.C., NAGEL, G.A., DICK, H.J., OBRECHT, J.P.: Nebenwirkungen der Zytostatika. Schweiz, med. Wschr. 103, 1252 (1973).

    CAS  Google Scholar 

  8. NAGEL, G.A., REGNOTTO, M., SARTORIüS, J.: Die Zytostatika: Dosierung, Nebenwirkungen, Therapieregeln. Schweiz. Apoth.-Ztg. 112, 274 (1974).

    Google Scholar 

  9. SKIPPER, H.E., HUTCHINSON, D.J., SCHABEL, F.M., SCHMIDT, L.H., GOLDIN, A., BROCKMAN, R.W., VENDITTI, J.M., WODINSKY, I.: A quick reference chart on cross resistance between anticancer agents. Cancer Chemother. Rep. Part 1, 56, 493 (1972).

    PubMed  CAS  Google Scholar 

  10. TRUHAUT, R. (Ed.): Potential carcinogenic hazards from drugs. UICC Monograph Series Vol.7. Berlin-Heidelberg-New York: Springer 1967.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Inselspital, Onkologische Station, CH-3010, Bern, Schweiz

    K. W. Brunner

  2. Kantonsspital Basel, Dept. für Innere Medizin, 1. Medizinische Universitäts-Klinik, Abt. für Onkologie, CH-4004, Basel, Schweiz

    G. A. Nagel

Authors
  1. K. W. Brunner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. A. Nagel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Inselspital, Onkologische Station, CH-3010, Bern, Schweiz

    K. W. Brunner

  2. Kantonsspital Basel, Dept. für Innere Medizin, 1. Medizinische Universitäts-Klinik, Abt. für Onkologie, CH-4004, Basel, Schweiz

    G. A. Nagel

Rights and permissions

Reprints and permissions

Copyright information

© 1976 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Brunner, K.W., Nagel, G.A. (1976). Gebräuchliche Hormone und Zytostatika. In: Brunner, K.W., Nagel, G.A. (eds) Internistische Krebstherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-96296-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-96296-7_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-07455-7

  • Online ISBN: 978-3-642-96296-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation